Literature DB >> 20129711

[The shadow of "RALES" is long].

Elisa Pereira, Agustín Carreño, Mazine Bennouna, Isabel Ferreras.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20129711      PMCID： PMC7024461          DOI： 10.1016/j.aprim.2009.10.024

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  4 in total

1.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2005-09-13       Impact factor: 29.690

2.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

3.  Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Authors:  David N Juurlink; Muhammad M Mamdani; Douglas S Lee; Alexander Kopp; Peter C Austin; Andreas Laupacis; Donald A Redelmeier
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

4.  ["Occult" renal insufficiency due to evaluating renal function using only serum creatinine].

Authors:  G Fernández-Fresnedo; A L M de Francisco; E Rodrigo; C Piñera; I Herráez; J C Ruiz; M Arias
Journal:  Nefrologia       Date:  2002       Impact factor: 2.033
  4 in total
  1 in total

Review 1.  The "FIFTY SHADOWS" of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease.

Authors:  Gregorio Romero-González; Jordi Bover; Javier Arrieta; Davide Salera; Maribel Troya; Fredzzia Graterol; Pablo Ureña-Torres; Mario Cozzolino; Luca Di Lullo; Pietro E Cippà; Marina Urrutia; Javier Paúl-Martinez; Ramón Boixeda; José Luis Górriz; Jordi Ara; Antoni Bayés-Genís; Antonio Bellasi; Claudio Ronco
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.